Pro-Dex (NASDAQ:PDEX) Stock Price Passes Above 200 Day Moving Average - Should You Sell?

Key Points

• Pro‑Dex stock broke above its 200‑day moving average, trading as high as $50.06 and last at $48.98 versus the 200‑day MA of $38.09 (volume 30,677).
• Quarterly results topped estimates: EPS $0.66 vs. $0.59 expected and revenue $18.66M vs. $17.30M, with a 15.73% net margin and 22.53% return on equity.
• Analyst and valuation snapshot: Consensus rating is a "Moderate Buy" with a $56 target, one Buy and one Hold on file, and a market cap of about $157.2M (P/E 14.41).

Shares of Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $38.09 and traded as high as $50.06. Pro-Dex shares last traded at $48.98, with a volume of 30,677 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a "hold (c)" rating on shares of Pro-Dex in a research report on Monday, December 29th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Pro-Dex has an average rating of "Moderate Buy" and a consensus target price of $56.00.

Pro-Dex Stock Down 0.6%

The business's 50-day moving average is $43.22 and its two-hundred day moving average is $38.09. The firm has a market capitalization of $157.23 million, a price-to-earnings ratio of 14.41 and a beta of -0.04. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.25 and a current ratio of 4.03.

Pro-Dex (NASDAQ:PDEX - Get Free Report) last issued its quarterly earnings data on Thursday, January 29th. The medical instruments supplier reported $0.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.59 by $0.07. Pro-Dex had a net margin of 15.73% and a return on equity of 22.53%. The firm had revenue of $18.66 million during the quarter, compared to analysts' expectations of $17.30 million. On average, equities analysts anticipate that Pro-Dex, Inc. will post 2 earnings per share for the current year.

Institutional Trading of Pro-Dex

A number of large investors have recently made changes to their positions in the company. Police & Firemen s Retirement System of New Jersey acquired a new stake in Pro-Dex during the 2nd quarter worth $28,000. Los Angeles Capital Management LLC acquired a new position in Pro-Dex in the fourth quarter valued at about $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Pro-Dex in the second quarter valued at about $50,000. Bank of America Corp DE increased its holdings in shares of Pro-Dex by 173.3% in the second quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier's stock worth $74,000 after acquiring an additional 1,073 shares in the last quarter. Finally, AlphaQuest LLC bought a new stake in shares of Pro-Dex in the third quarter worth about $71,000. Institutional investors own 15.28% of the company's stock.

About Pro-Dex

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.